{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:44:55Z","timestamp":1789058695075,"version":"build-2803163510"},"reference-count":16,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec id=\"ab-ebr260001-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Endothelial graft failure after Descemet stripping automated endothelial keratoplasty (DSAEK) is a clinically relevant problem, and the current standard treatment is repeat keratoplasty, which carries risks of surgery-related complications and depends on donor availability. Cultured human corneal endothelial cell (HCEC) therapy injection represents a potentially regenerative alternative; however, safety and outcomes for failed DSAEK grafts have not been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260001-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate clinical outcomes of cultured HCEC therapy in eyes with endothelial graft failure after prior DSAEK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260001-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This prospective case series included 4 consecutive eyes with DSAEK graft failure treated with cultured HCEC therapy at Tokyo Dental College Ichikawa General Hospital in 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260001-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>Intracameral injection of cultured HCEC therapy for endothelial dysfunction after DSAEK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260001-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Best-corrected visual acuity (BCVA, in logMAR [Snellen equivalent]), central corneal thickness (CCT), endothelial cell density (ECD), and intraocular pressure (IOP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260001-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 4 eyes from 4 patients (mean [SD] age, 68.8 [9.3] years; 3 male [75%]) were included in this study. Mean (SD) BCVA improved from 1.93 (0.59) (Snellen, 20\/1700) preoperatively to 0.46 (0.64) (Snellen, 20\/60) at 3 months, with a mean change of \u22121.46 logMAR (15 Snellen lines; 95 CI, \u22121.87 to \u22121.05). Mean (SD) CCT changed from 900 (152) \u00b5m preoperatively to 641 (72) \u00b5m at 3 months with mean (SD) changes of \u2212260 (73) \u00b5m (95% CI, \u2212483 to \u221236 \u00b5m). Mean (SD) ECD could not be measured preoperatively because of severe corneal edema and was 1480\u2009(989) cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      at 1 month and 2150\u2009(723) cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      at 3 months. Mean (SD) IOP changed from 10 (2.1) mm Hg preoperatively to 13 (5.2) mm Hg at 3 months, with a mean (SD) change of +3.5 (2.1) mm Hg (95% CI, \u22127.6 to 14.6 mm Hg). Cystoid macular edema was observed in 2 eyes and was managed with topical diclofenac and sub-Tenon injections of triamcinolone acetonide. No other intraoperative and postoperative complications, including IOP elevation, infection, or graft detachment, were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ebr260001-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Although limited to 4 eyes without controls, these findings suggest that cultured HCECs transplantation may be a feasible option for eyes with DSAEK graft failure. Confirmation in larger, controlled studies with longer follow-up is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2026.0812","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:30:36Z","timestamp":1776353436000},"page":"474","source":"Crossref","is-referenced-by-count":3,"title":["Cultured Human Corneal Endothelial Cell Injection for Endothelial Graft Failure After DSAEK"],"prefix":"10.1001","volume":"144","author":[{"given":"Rintaro","family":"Ogino","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Shirane","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyo","family":"Shijo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Yagi-Yaguchi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tomida","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"ebr260001r1","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/01.ico.0000214224.90743.01","article-title":"Descemet-stripping automated endothelial keratoplasty.","volume":"25","author":"Gorovoy","year":"2006","journal-title":"Cornea"},{"issue":"2","key":"ebr260001r2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1442-9071.2010.02213.x","article-title":"Endothelial keratoplasty: a review.","volume":"38","author":"Price","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"ebr260001r3","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.ophtha.2012.04.031","article-title":"Descemet stripping endothelial keratoplasty: long-term graft survival and risk factors for failure in eyes with preexisting glaucoma.","volume":"119","author":"Anshu","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"ebr260001r4","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.ophtha.2016.04.049","article-title":"Five-year graft survival comparing Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty.","volume":"123","author":"Ang","year":"2016","journal-title":"Ophthalmology"},{"issue":"20","key":"ebr260001r5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz5195","article-title":"Pathological processes in aqueous humor due to iris atrophy predispose to early corneal graft failure in humans and mice.","volume":"6","author":"Yamaguchi","year":"2020","journal-title":"Sci Adv"},{"issue":"2","key":"ebr260001r6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ophtha.2010.06.032","article-title":"Secondary graft failure and repeat endothelial keratoplasty after Descemet stripping automated endothelial keratoplasty.","volume":"118","author":"Letko","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"ebr260001r7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and donor need.","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"ebr260001r8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1056\/NEJMoa1712770","article-title":"Injection of cultured corneal endothelial cells for bullous keratopathy.","volume":"378","author":"Kinoshita","year":"2018","journal-title":"N Engl J Med"},{"key":"ebr260001r9","doi-asserted-by":"publisher","first-page":"26113","DOI":"10.1038\/srep26113","article-title":"Rho kinase inhibitor enables cell-based therapy for corneal endothelial dysfunction.","volume":"6","author":"Okumura","year":"2016","journal-title":"Sci Rep"},{"key":"ebr260001r10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2018.11.014","article-title":"Clinical outcomes of Descemet membrane endothelial keratoplasty in eyes with a glaucoma drainage device.","volume":"199","author":"Birbal","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"ebr260001r11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/ICO.0000000000003050","article-title":"Graft survival, graft rejection, and glaucoma in a consecutive series of Descemet stripping endothelial keratoplasty.","volume":"42","author":"Patel","year":"2023","journal-title":"Cornea"},{"key":"ebr260001r12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ajo.2021.08.005","article-title":"Long-term outcomes of Descemet stripping endothelial keratoplasty: 10-year graft survival and endothelial cell loss.","volume":"234","author":"Fu","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"ebr260001r13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2020.05.020","article-title":"Four-year survival of descemet membrane endothelial keratoplasty in patients with previous glaucoma surgery.","volume":"218","author":"Sorkin","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"ebr260001r14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"ebr260001r15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ajo.2025.08.022","article-title":"Association between intracellular dark spots on specular microscopy and endothelial cell loss after penetrating keratoplasty.","volume":"280","author":"Kanda","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"ebr260001r16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/bjo-2024-325702","article-title":"Intracellular dark spots are associated with endothelial cell loss after Descemet stripping automated endothelial keratoplasty.","volume":"109","author":"Mori-Ogiwara","year":"2025","journal-title":"Br J Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2847390\/jamaophthalmology_ogino_2026_br_260001_1778698703.30386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:00:52Z","timestamp":1779375652000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2847390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2026.0812","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}